Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Equity Ratio (2021 - 2025)

Historic Equity Ratio for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 0.47.

  • Rxo's Equity Ratio fell 40.79% to 0.47 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.47, marking a year-over-year decrease of 40.79%. This contributed to the annual value of 0.47 for FY2025, which is 40.79% down from last year.
  • Latest data reveals that Rxo reported Equity Ratio of 0.47 as of Q4 2025, which was down 40.79% from 0.49 recorded in Q3 2025.
  • Over the past 5 years, Rxo's Equity Ratio peaked at 0.52 during Q4 2021, and registered a low of 0.29 during Q4 2022.
  • In the last 5 years, Rxo's Equity Ratio had a median value of 0.47 in 2025 and averaged 0.41.
  • In the last 5 years, Rxo's Equity Ratio crashed by 4414.08% in 2022 and then soared by 6063.68% in 2024.
  • Quarter analysis of 5 years shows Rxo's Equity Ratio stood at 0.52 in 2021, then tumbled by 44.14% to 0.29 in 2022, then increased by 12.61% to 0.33 in 2023, then surged by 45.07% to 0.47 in 2024, then decreased by 0.41% to 0.47 in 2025.
  • Its last three reported values are 0.47 in Q4 2025, 0.49 for Q3 2025, and 0.5 during Q2 2025.